IndiGlobal Labs CRO

IndiGlobal Labs CRO is a Contract Research and Testing Organization (CRTO), DCGI Approved, offering clinical research services based in Hyderabad, India. The company prides itself on combining innovation and knowledge with cutting-edge facilities. With a team experienced in successfully navigating regulatory inspections from various authorities, including USFDA, CDSCO, EMEA, WHO, MHRA, ANVISA, Costa Rica, NPRA-Malaysia, and ANSM-France, IndiGlobal Labs ensures compliance with GCP, GLP, and Quality Management System requirements. The company's dedication to quality, safety, ethics, data integrity, and human principles, along with two decades of team experience, innovative designs, and the capability to develop complex bioanalytical methods, set it apart.

IndiGlobal Labs prides itself on its independence, adaptability, transparency, experience, timeliness, cost-effectiveness, and ISO certified QMS. The company offers a range of services, including end-to-end clinical research services, BA/BE, phase trials, glycaemic index studies, human performance studies, and claim studies. Its facilities include 52 beds, a fully equipped ICU, pharmacy, on-site ambulance, bedside emergency panic buttons, bioanalytical with LC-MS/MS, NABL accredited in-house pathology lab, 21 CFR Part 11 compliant computerized systems, door access control, volunteer information management software, volunteer cross-participation software, daily, weekly, and project backups, and sample storage equipment. Founded in 2021, IndiGlobal Labs CRO operates in the pharmaceutical industry.

For those interested in overcoming their BA/BE obstacles, IndiGlobal Labs CRO encourages reaching out to discover opportunities and encourages visiting its website at www.indigloballabs.com to view its capabilities in detail.